Opticyte

company

About

Opticyte is transforming care for the leading causes of organ failure, including sepsis, with real-time measurements.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.10M
Industries
Medical Device
Founded date
Jan 1, 2016
Number Of Employee
1 - 10
Operating Status
Active

Opticyte, Inc, a medical device innovator developing proprietary advanced algorithms and tailored optical spectroscopy technology to measure and detect low oxygen levels in cells to prevent organ failure. Opticyte is developing the first Cell O2 Monitor for reducing organ failure. Founded in 2016, Opticyte, Inc, is a spinoff from the University of Washington. Headquartered in Seattle, WA, Opticyte employs engineering, regulatory, and communications teams with deep experience in bringing medical devices to market.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$1.10M
Opticyte has raised a total of $1.10M in funding over 2 rounds. Their latest funding was raised on Jun 1, 2016 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 1, 2016 Grant $1.10M 1 National Institutes of Health Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Opticyte is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant